| WB | 咨询技术 | Human,Mouse,Rat |
| IF | 咨询技术 | Human,Mouse,Rat |
| IHC | 1/50-1/200 | Human,Mouse,Rat |
| ICC | 技术咨询 | Human,Mouse,Rat |
| FCM | 咨询技术 | Human,Mouse,Rat |
| Elisa | 1/5000-1/10000 | Human,Mouse,Rat |
| Aliases | EB1; SCAF1; SCAFI; SIG81; COX7AR; COX7RP |
| WB Predicted band size | 13 kDa |
| Host/Isotype | Rabbit IgG |
| Antibody Type | Primary antibody |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human, Mouse |
| Immunogen | Fusion protein of human COX7A2L |
| Formulation | Purified antibody in PBS with 0.05% sodium azide and 50% glycerol. |
+ +
以下是3篇涉及COX7A2L抗体的代表性文献(内容基于公开研究概括，具体文献请核实数据库)：
---
1. **文献名称**: *Supercomplex Assembly Determines Electron Flux in the Mitochondrial Electron Transport Chain*
**作者**: Lapuente-Brun, E. et al. (2013)
**摘要**: 研究利用COX7A2L抗体通过免疫印迹和免疫沉淀技术，证明COX7A2L蛋白在哺乳动物线粒体呼吸链超级复合体(Respirasome)组装中的关键作用，并发现其缺失导致呼吸链功能异常。
2. **文献名称**: *COX7A2L is a Mitochondrial Complex III-Assembly Factor Critical for Mammalian Respiration*
**作者**: Vercellino, I. & Sazanov, L.A. (2022)
**摘要**: 通过COX7A2L抗体的免疫荧光定位，揭示了该蛋白在调控线粒体复合体III和IV的动态组装中的功能，并发现其突变与能量代谢疾病相关。
3. **文献名称**: *Regulation of Mitochondrial Respiratory Chain Structure and Function by Estrogen-related Receptors*
**作者**: Hüttemann, M. et al. (2012)
**摘要**: 研究使用COX7A2L抗体分析组织特异性表达模式，发现该蛋白在不同器官中通过调节呼吸链超级复合体形成影响能量代谢效率，尤其在心脏和骨骼肌中作用显著。
---
如需具体文献DOI或验证详细信息，建议通过PubMed或Web of Science检索标题及作者。
The COX7A2L antibody targets cytochrome c oxidase subunit 7A-related protein 2-like (COX7A2L), a key regulatory component of mitochondrial respiratory chain supercomplex assembly. Also known as SCAF1 (supercomplex assembly factor 1), this nuclear-encoded protein facilitates the organization of respiratory complexes III and IV into functional higher-order structures, optimizing electron transport efficiency and energy production. Antibodies against COX7A2L are widely used in mitochondrial research to investigate respiratory chain organization, metabolic adaptations, and cellular stress responses.
These antibodies enable detection of COX7A2L expression through techniques like Western blotting, immunofluorescence, and immunohistochemistry, helping researchers map its tissue-specific distribution and subcellular localization. Studies utilizing COX7A2L antibodies have revealed its role in modulating oxidative phosphorylation capacity, apoptosis regulation, and cellular responses to hypoxia. Dysregulation of COX7A2L has been implicated in metabolic disorders, neurodegenerative diseases, and cancer progression.
Commercial COX7A2L antibodies are typically raised in rabbit or mouse hosts, validated for specificity across human and model organisms. Recent applications include exploring its interaction with hypoxia-inducible factors and its potential as a biomarker for mitochondrial dysfunction. Proper validation using knockout controls remains essential due to variable migration patterns observed in gel electrophoresis across cell types.
×
